Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of 20s Proteasome market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of 20s Proteasomemarket, defines the market attractiveness level of 20s Proteasome market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of 20s Proteasome industry, describes the types of 20s Proteasome market, the applications of major players and the market size, and deeply analyzes the current situation of the global 20s Proteasome market and the development prospects and opportunities of 20s Proteasome industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global 20s Proteasome market in Chapter 13.
By Player:
Amgen Inc
Celgene Corp
By Type:
Marizomib
Oprozomib
Carfilzomib
VPEA-002
Others
By End-User:
Colon Cancer
Lymphoma
Malignant Glioma
Neuroendocrine Cancer
Ovarian Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 20s Proteasome Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 20s Proteasome Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 20s Proteasome Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 20s Proteasome Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise 20s Proteasome Market Analysis and Outlook to 2022
-
7.1 Global 20s Proteasome Consumption (2017-2022)
-
7.2 United States 20s Proteasome Consumption (2017-2022)
-
7.3 Europe 20s Proteasome Consumption (2017-2022)
-
7.4 China 20s Proteasome Consumption (2017-2022)
-
7.5 Japan 20s Proteasome Consumption (2017-2022)
-
7.6 India 20s Proteasome Consumption (2017-2022)
-
7.7 South Korea 20s Proteasome Consumption (2017-2022)
8 Region and Country-wise 20s Proteasome Market Analysis and Outlook to 2028
-
8.1 Global 20s Proteasome Consumption Forecast (2022-2028)
-
8.2 United States 20s Proteasome Consumption Forecast (2022-2028)
-
8.3 Europe 20s Proteasome Consumption Forecast (2022-2028)
-
8.4 China 20s Proteasome Consumption Forecast (2022-2028)
-
8.5 Japan 20s Proteasome Consumption Forecast (2022-2028)
-
8.6 India 20s Proteasome Consumption Forecast (2022-2028)
-
8.7 South Korea 20s Proteasome Consumption Forecast (2022-2028)
9 Global 20s Proteasome Market Outlook by Types and Applications to 2022
-
9.1 Global 20s Proteasome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Marizomib Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oprozomib Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Carfilzomib Consumption and Growth Rate (2017-2022)
-
9.1.4 Global VPEA-002 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global 20s Proteasome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Colon Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Malignant Glioma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Neuroendocrine Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global 20s Proteasome Market Outlook by Types and Applications to 2028
-
10.1 Global 20s Proteasome Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Marizomib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oprozomib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Carfilzomib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global VPEA-002 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global 20s Proteasome Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Malignant Glioma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Neuroendocrine Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global 20s Proteasome Import and Export Analysis (Top 5 Countries)
-
11.1 Global 20s Proteasome Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global 20s Proteasome Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 20s Proteasome Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global 20s Proteasome Market Competitive Analysis
-
14.1 Amgen Inc
-
14.1.1 Amgen Inc Company Details
-
14.1.2 Amgen Inc 20s Proteasome Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Amgen Inc 20s Proteasome Product and Service
-
14.2 Celgene Corp
-
14.2.1 Celgene Corp Company Details
-
14.2.2 Celgene Corp 20s Proteasome Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Celgene Corp 20s Proteasome Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of 20s Proteasome
-
Figure 20s Proteasome Picture
-
Table Global 20s Proteasome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global 20s Proteasome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global 20s Proteasome Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global 20s Proteasome Consumption by Country (2017-2022)
-
Figure United States 20s Proteasome Consumption and Growth Rate (2017-2022)
-
Table Europe 20s Proteasome Consumption and Growth Rate (2017-2022)
-
Figure China 20s Proteasome Consumption and Growth Rate (2017-2022)
-
Figure Japan 20s Proteasome Consumption and Growth Rate (2017-2022)
-
Figure India 20s Proteasome Consumption and Growth Rate (2017-2022)
-
Figure South Korea 20s Proteasome Consumption and Growth Rate (2017-2022)
-
Figure Global 20s Proteasome Consumption Forecast by Country (2022-2028)
-
Figure United States 20s Proteasome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe 20s Proteasome Consumption Forecast and Growth Rate (2022-2028)
-
Figure China 20s Proteasome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan 20s Proteasome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India 20s Proteasome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea 20s Proteasome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Marizomib Consumption and Growth Rate (2017-2022)
-
Figure Global Oprozomib Consumption and Growth Rate (2017-2022)
-
Figure Global Carfilzomib Consumption and Growth Rate (2017-2022)
-
Figure Global VPEA-002 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Colon Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Malignant Glioma Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroendocrine Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Marizomib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oprozomib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Carfilzomib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VPEA-002 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Malignant Glioma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neuroendocrine Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global 20s Proteasome Import by Region (Top 5 Countries) (2017-2028)
-
Table Global 20s Proteasome Export by Region (Top 5 Countries) (2017-2028)
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc 20s Proteasome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc 20s Proteasome Product and Service
-
Table Celgene Corp (Foundation Year, Company Profile and etc.)
-
Table Celgene Corp 20s Proteasome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corp 20s Proteasome Product and Service
-
